A phase II trial of Cloretazine (VNP40101M) [laromustine] for patients with relapsed or refractory small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2009
At a glance
- Drugs Laromustine (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 07 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jan 2008 Status changed from recruiting to in progress.
- 20 Nov 2007 New trial centres added.